Crossmark

Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

Crossref DOI link: https://doi.org/10.1186/s41100-018-0166-7

Published Online: 2018-06-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashida, Akira https://orcid.org/0000-0001-5972-946X
Matsumura, Hideki

Fujii, Yuko

Nakakura, Hyogo

Shirasu, Akihiko

Tamai, Hiroshi
License Information

Text and Data Mining valid from 2018-06-20
More Information

Article History

Received: 16 March 2018

Accepted: 20 May 2018

First Online: 20 June 2018

Ethics approval and consent to participate

: The manuscript and informed consent form were approved by the ethics committee of Osaka Medical College (approval number: 2017-OMC-2).

: Because the patient had severe intellectual disability due to TANDs, we gave the patient’s mother an opportunity to read the manuscript and obtained her written consent for publication.

: Hiroshi Tamai received a lecture fee from Novartis Pharma. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.